Clinical Trial Update: Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

View source ↗

Summary

This completed clinical trial from Stanford explored serum markers associated with tumor hypoxia in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Stanford University | Conditions: Lung Cancer | Status: COMPLETED